We are live on
!
Find out more
KBC Group Portfolio holdings
AUM
$39.9B
1-Year Est. Return
29.7%
This Fund
S&P 500
This Quarter
Est. Return
-13.93%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$20B
AUM Growth
-$5.25B
(-21%)
Cap. Flow
-$1.13B
Cap. Flow
% of AUM
-5.62%
Top 10 Holdings %
Top 10 Hldgs %
21.83%
Holding
1,650
New
389
Increased
426
Reduced
533
Closed
104
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$109M |
| 2 |
AbbVie
ABBV
|
+$68.7M |
| 3 |
Oracle
ORCL
|
+$63.5M |
| 4 |
Coca-Cola
KO
|
+$54.4M |
| 5 |
Abbott
ABT
|
+$52.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$112M |
| 2 |
Apple
AAPL
|
+$97.1M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$87.3M |
| 4 |
NVIDIA
NVDA
|
+$66.6M |
| 5 |
Microsoft
MSFT
|
+$63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.14% |
| 2 | Healthcare | 21.45% |
| 3 | Financials | 13.18% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Consumer Staples | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Microsoft
MSFT
$2.84T
| $1.16B | 5.79% |
4,517,550
-232,170
| -5% | -$63M |
|
|
2
Apple
AAPL
$4.89T
| $773M | 3.86% |
5,656,579
-640,894
| -10% | -$97.1M |
|
3
UnitedHealth
UNH
$382B
| $407M | 2.03% |
791,743
-43,718
| -5% | -$22M |
|
4
Thermo Fisher Scientific
TMO
$211B
| $357M | 1.78% |
657,924
-67,641
| -9% | -$37.2M |
|
|
5
Alphabet (Google) Class C
GOOG
$3.9T
| $341M | 1.7% |
3,121,840
-738,740
| -19% | -$87.3M |
|
6
PepsiCo
PEP
$186B
| $310M | 1.55% |
1,860,911
+184,463
| +11% | +$31.1M |
|
|
7
Amazon
AMZN
$2.5T
| $286M | 1.43% |
2,691,412
-892,808
| -25% | -$112M |
|
8
Visa
V
$677B
| $258M | 1.29% |
1,308,983
+148,385
| +13% | +$30.7M |
|
9
Danaher
DHR
$135B
| $242M | 1.21% |
1,077,381
+34,744
| +3% | +$8M |
|
|
10
NVIDIA
NVDA
$5.01T
| $240M | 1.2% |
15,856,390
-3,530,620
| -18% | -$66.6M |
|
11
Bristol-Myers Squibb
BMY
$127B
| $239M | 1.19% |
3,101,126
+79,629
| +3% | +$6.06M |
|
12
Pfizer
PFE
$140B
| $213M | 1.06% |
4,063,162
+671,884
| +20% | +$34.2M |
|
13
Johnson & Johnson
JNJ
$634B
| $212M | 1.06% |
1,194,956
-89,185
| -7% | -$15.9M |
|
14
Walt Disney
DIS
$165B
| $209M | 1.04% |
2,213,872
-156,062
| -7% | -$17.3M |
|
15
Mondelez International
MDLZ
$77.7B
| $209M | 1.04% |
3,364,971
+678,254
| +25% | +$42.8M |
|
16
Nike
NKE
$61.9B
| $201M | 1% |
1,970,328
+60,646
| +3% | +$7.17M |
|
17
Eli Lilly
LLY
$1.07T
| $196M | 0.98% |
604,432
-62,893
| -9% | -$18.9M |
|
|
18
AbbVie
ABBV
$458B
| $187M | 0.93% |
1,219,556
+449,340
| +58% | +$68.7M |
|
|
19
Merck
MRK
$324B
| $181M | 0.9% |
1,988,244
+1,230,521
| +162% | +$109M |
|
20
Procter & Gamble
PG
$343B
| $171M | 0.85% |
1,187,565
+75,881
| +7% | +$11.4M |
|
21
Estee Lauder
EL
$29B
| $171M | 0.85% |
669,662
+95,807
| +17% | +$24.3M |
|
|
22
Alphabet (Google) Class A
GOOGL
$3.91T
| $166M | 0.83% |
1,521,180
-105,240
| -6% | -$12.4M |
|
23
S&P Global
SPGI
$126B
| $164M | 0.82% |
487,200
-24,865
| -5% | -$8.86M |
|
24
Morgan Stanley
MS
$337B
| $160M | 0.8% |
2,108,084
-132,567
| -6% | -$10.9M |
|
|
25
Abbott
ABT
$180B
| $158M | 0.79% |
1,450,442
+459,331
| +46% | +$52.2M |
|
Similar funds
HF
KBC Group's Q2 2022 Portfolio in Review
As of Q2 2022, KBC Group held 1,650 positions worth $20B, down 21% from $25.3B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
KBC Group withdrew a net $1.13B in Q2 2022, closing 104 positions and reducing 533 holdings. Its most notable exit was Cerner Corp, an estimated $17.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, KBC Group opened a new position in AstraZeneca worth $1.34M.
- KBC Group's largest Q2 2022 buy was AstraZeneca: 10,181 shares worth $1.34M.
- KBC Group added most to Merck in Q2 2022, an estimated $109M increase.
- KBC Group's biggest Q2 2022 reduction was Amazon, cutting an estimated $112M.
- KBC Group fully exited Cerner Corp in Q2 2022, selling an estimated $17.5M.
- KBC Group's ten largest holdings make up 22% of its $20B portfolio in Q2 2022.
- KBC Group opened 389 new positions and closed 104 in Q2 2022.
- KBC Group's portfolio value fell 21% quarter-over-quarter to $20B.
Based on KBC Group's 13F filing for Q2 2022, filed 26 Jul 2022.